Cargando…
RNA-Seq of Kaposi’s sarcoma reveals alterations in glucose and lipid metabolism
Kaposi’s sarcoma-associated herpesvirus (KSHV) is the etiologic agent of Kaposi’s sarcoma (KS). It is endemic in a number of sub-Saharan African countries with infection rate of >50%. The high prevalence of HIV-1 coupled with late presentation of advanced cancer staging make KS the leading cancer...
Autores principales: | Tso, For Yue, Kossenkov, Andrew V., Lidenge, Salum J., Ngalamika, Owen, Ngowi, John R., Mwaiselage, Julius, Wickramasinghe, Jayamanna, Kwon, Eun Hee, West, John T., Lieberman, Paul M., Wood, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792027/ https://www.ncbi.nlm.nih.gov/pubmed/29352292 http://dx.doi.org/10.1371/journal.ppat.1006844 |
Ejemplares similares
-
Comparative transcriptome analysis of endemic and epidemic Kaposi’s sarcoma (KS) lesions and the secondary role of HIV-1 in KS pathogenesis
por: Lidenge, Salum J., et al.
Publicado: (2020) -
Lack of CD8(+) T-cell co-localization with Kaposi’s sarcoma-associated herpesvirus infected cells in Kaposi’s sarcoma tumors
por: Lidenge, Salum J., et al.
Publicado: (2020) -
Viral and Immunological Analytes are Poor Predictors of the Clinical Treatment Response in Kaposi’s Sarcoma Patients
por: Lidenge, Salum J., et al.
Publicado: (2020) -
Outcome markers of ART-treated HIV+ patients with early stage Kaposi’s sarcoma
por: Ngalamika, Owen, et al.
Publicado: (2020) -
Antiretroviral Therapy for HIV-Associated Cutaneous Kaposi's Sarcoma: Clinical, HIV-Related, and Sociodemographic Predictors of Outcome
por: Ngalamika, Owen, et al.
Publicado: (2021)